Weekly News Recap #Phispers
Lundbeck acquires Longboard for US$ 2.6 billion; Roche’s Itovebi bags FDA nod for breast cancer
This week’s is a double dose Phispers, as we return from a one-week break due to CPhI Worldwide. The fortnight saw severa...
Impressions : 1452
FDA to consider psychedelic-assisted drug for treating PTSD; Novartis buys Mariana Oncology for up to US$ 1.75 bn
Last year, the US Food and Drug Administration (FDA) had published a new draft guidance for researchers investigating the use o...
Impressions : 1153
BMS buys biopharma firm MyoKardia for US$ 13.1 billion; Concerns emerge over quality of acetazolamide
This week, Phispers has more updates on Covid-19 vaccines and therapies.
In the US, President Donald Trump contracted the vir...
Impressions : 88812
Trump admin wants to pull global supply chains out of China; FDA okays remdesivir for emergency use
This week, Phispers has news on remdesivir, Gilead’s investigational antiviral drug.
The USFDA has issued an emergency ...
Impressions : 67089
FDA highlights data-integrity concerns at Pfizer’s India unit; FDA requests removal of all ranitidine products
This week, N-nitrosodimethylamine (NDMA) is back in news as the FDA requests manufacturers to withdraw ranitidine from the mark...
Impressions : 3646
Mylan’s valsartan facility gets FDA warning letter; US sues Gilead over HIV drug patents
This week, Phispers has news on Mylan’s valsartan facility in India receiving an FDA warning letter for nitrosamine conta...
Impressions : 4477
Sanofi pulls Zantac from US, Canada; FDA slams Chinese API manufacturer; DMF guidance update
This week, three drug distributors along with Teva, agreed with two Ohio counties to a US$ 260 million deal to avert the first ...
Impressions : 2710
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.